Clinuvel Pharmaceuticals
CUV.AX
#8517
Rank
NZ$0.51 B
Marketcap
NZ$10.29
Share price
0.00%
Change (1 day)
-14.83%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: NZ$58.82 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$62.5 Million. In 2025 the company made an earning of NZ$58.82 Million, an increase over its 2024 earnings that were of NZ$58.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025NZ$58.82 M0.26%
2024NZ$58.67 M11.35%
2023NZ$52.69 M28.31%
2022NZ$41.06 M22.8%
2021NZ$33.44 M112.63%
2020NZ$15.72 M-28.73%
2019NZ$22.06 M32.79%
2018NZ$16.62 M75.41%
2017NZ$9.47 M-332.52%
2016-NZ$4.08 Million-70.68%
2015-NZ$13.9 Million53.78%
2014-NZ$9.04 Million-16.1%
2013-NZ$10.78 Million-37.92%
2012-NZ$17.36 Million-18.19%
2011-NZ$21.22 Million25.31%
2010-NZ$16.93 Million-21.53%
2009-NZ$21.58 Million-11.27%
2008-NZ$24.32 Million80.4%
2007-NZ$13.48 Million-2.46%
2006-NZ$13.82 Million-5.35%
2005-NZ$14.6 Million60.55%
2004-NZ$9.1 Million97.37%
2003-NZ$4.61 Million50.62%
2002-NZ$3.06 Million121.22%
2001-NZ$1.39 Million254.48%
2000-NZ$0.4 Million